-
Market Alert: Advanced Emissions Solutions (NASDAQ:ADES), PhotoMedex (NASDAQ:PHMD), Orbotech (NASDAQ:ORBK), CHS (NASDAQ:CHSCP), Cleveland BioLabs (NASDAQ:CBLI)
Advanced Emissions Solutions (NASDAQ:ADES) announced that as expected, it received a notification letter from The NASDAQ Stock Market LLC on January 30, 2015 indicating that the NASDAQ Listing Qualifications Hearings Panel had determined to delist the shares of the Company from The NASDAQ Capital Market (“NASDAQ”) and, accordingly, suspend trading in the Company’s shares effective…
-
5 Stocks in Dramatic Moves: Idera Pharmaceuticals (NASDAQ:IDRA), Energy XXI Ltd (NASDAQ:EXXI), PhotoMedex (NASDAQ:PHMD), Johnson & Johnson (NYSE:JNJ), Voxeljet (NYSE:VJET)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), on 26 January announced the appointments of R. Clayton Fletcher as Senior Vice President, Business Development and Strategic Planning, and Jim Baker as Executive Director, Market Development. On Monday shares of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) closed at $4.21. On 27 January Energy XXI Ltd (NASDAQ:EXXI) regretfully announced the passing of Mr.…
-
Why These Are Hot: Straight Path Communications Inc. (NYSEMKT:STRP), Unit Corporation (NYSE:UNT), PhotoMedex (NASDAQ:PHMD), First Mid-Illinois Bancshares (NASDAQ:FMBH), RCS Capital (NYSE:RCAP)
Straight Path Communication Inc.’s (NYSEMKT:STRP) Annual Meeting of Stockholders was held on January 12, 2015 (the “Meeting”). Stockholders voted on the matters. A majority of the votes present or represented at the Meeting by the holders of shares entitled to vote on on the election of directors were voted in connection with each of the…
-
What’s Hot: Merck & Co. Inc. (NYSE:MRK), PhotoMedex (NASDAQ:PHMD), AV Homes (NASDAQ:AVHI), Johnson & Johnson (NYSE:JNJ), SunEdison (NYSE:SUNE)
Merck & Co. Inc. (NYSE:MRK) known as MSD outside the US and Canada, and Eli Lilly and Company (LLY) announced an oncology clinical trial collaboration to evaluate the safety, tolerability and efficacy of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Lilly compounds in multiple clinical trials. On Tuesday shares of Merck & Co. Inc.…
-
Stocks News Alert: PhotoMedex (NASDAQ:PHMD), JetBlue Airways Corporation (NASDAQ:JBLU), Freescale Semiconductor, (NYSE:FSL), Incyte Corporation (NASDAQ:INCY), CatchMark Timber Trust (NYSE:CTT)
PhotoMedex (NASDAQ:PHMD) CFO Dennis M. Mcgrath sold 55,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $1.14, for a total transaction of $62,700.00. Following the completion of the transaction, the chief financial officer now directly owns…
-
Big Movers: AbbVie Inc. (NYSE:ABBV), China Jo-Jo Drugstores (NASDAQ:CJJD), G&K Services Inc. (NASDAQ:GK), ExamWorks Group (NYSE:EXAM), PhotoMedex (NASDAQ:PHMD)
On 20 December AbbVie Inc. (NYSE:ABBV) said that AbbVie Inc. (NYSE:ABBV) and Enanta Pharmaceuticals Inc. (ENTA)’s hepatitis C combination drug will be about 12 percent cheaper than its rival from Gilead Sciences Inc. (GILD), setting the stage for fierce competition for patients of the liver virus. AbbVie Inc. (NYSE:ABBV) in last trading activity moved down…
-
Top News : PTC Therapeutics (NASDAQ:PTCT), Magnum Hunter Resources Corp. (NYSE:MHR), Chimera Investment Corporation (NYSE:CIM), Rubicon Minerals Corporation (NYSEMKT:RBY), PhotoMedex (NASDAQ:PHMD)
On 23 December PTC Therapeutics, Inc. (NASDAQ:PTCT) announced that it has commenced a rolling submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for Translarna™ for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). A rolling submission allows completed portions of the application to be submitted and…
-
Morning Movers: Denbury Resources Inc. (NYSE:DNR), Facebook Inc (NASDAQ:FB), First NBC Bank Holding Company (NASDAQ:NBCB), PhotoMedex (NASDAQ:PHMD), FS Bancorp (NASDAQ:FSBW)
Shares of Denbury Resources Inc. (NYSE:DNR) have been given an average recommendation of “Hold” by the seventeen analysts that are covering the company, AnalystRatingsNetwork.com reports. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the company. The average 12-month…
-
Stocks on the move: PhotoMedex (NASDAQ:PHMD), VirnetX Holding Corp (NYSEMKT:VHC), Kinross Gold Corporation (NYSE:KGC), Safeway Inc. (NYSE:SWY), Citigroup Inc. (NYSE:C)
PhotoMedex (NASDAQ:PHMD) CFO Dennis M. Mcgrath sold 55,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $1.14, for a total transaction of $62,700.00. PhotoMedex, Inc. (NASDAQ:PHMD) in last trading activity increased 19.18% to close at $1.74.…
-
Best Stocks: PhotoMedex (NASDAQ:PHMD), Johnson & Johnson (NYSE:JNJ), OSI Systems (NASDAQ:OSIS), Varian Medical Systems (NYSE:VAR), Oncothyreon Inc (NASDAQ:ONTY)
PhotoMedex (NASDAQ:PHMD) CFO Dennis M. Mcgrath sold 55,000 shares of PhotoMedex stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $1.14, for a total transaction of $62,700.00. PhotoMedex, Inc. (NASDAQ:PHMD) in last trading activity increased 26.32% to close at $1.44. Company weekly performance is -4.00% while its…